Atrial fibrillation and anabolic steroids

Mack L. Sullivan, Charles M. Martinez, E. John Gallagher

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

A young male bodybuilder, consuming large doses of anabolic steroids (AS), presented to the Emergency Department (ED) with symptomatic rapid atrial fibrillation (AF). Echocardiogram revealed significant septal hypokinesis, and posterior and septal wall thickness at the upper limit of normal for highly trained athletes. The atrial fibrillation had not recurred at 10 weeks after discontinuation of AS use. Consumption of these agents in athletes has been associated with hypertension, ischemic heart disease, hypertrophic cardiomyopathy, and sudden death.

Original languageEnglish (US)
Pages (from-to)851-857
Number of pages7
JournalJournal of Emergency Medicine
Volume17
Issue number5
DOIs
StatePublished - Sep 1999

Fingerprint

Testosterone Congeners
Athletes
Atrial Fibrillation
Hypertrophic Cardiomyopathy
Sudden Death
Myocardial Ischemia
Hospital Emergency Service
Hypertension

Keywords

  • Anabolic steroids
  • Atrial fibrillation
  • Dysrhythmia

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Atrial fibrillation and anabolic steroids. / Sullivan, Mack L.; Martinez, Charles M.; Gallagher, E. John.

In: Journal of Emergency Medicine, Vol. 17, No. 5, 09.1999, p. 851-857.

Research output: Contribution to journalArticle

Sullivan, Mack L. ; Martinez, Charles M. ; Gallagher, E. John. / Atrial fibrillation and anabolic steroids. In: Journal of Emergency Medicine. 1999 ; Vol. 17, No. 5. pp. 851-857.
@article{cb235992393b483daa7e64e1b2d0d819,
title = "Atrial fibrillation and anabolic steroids",
abstract = "A young male bodybuilder, consuming large doses of anabolic steroids (AS), presented to the Emergency Department (ED) with symptomatic rapid atrial fibrillation (AF). Echocardiogram revealed significant septal hypokinesis, and posterior and septal wall thickness at the upper limit of normal for highly trained athletes. The atrial fibrillation had not recurred at 10 weeks after discontinuation of AS use. Consumption of these agents in athletes has been associated with hypertension, ischemic heart disease, hypertrophic cardiomyopathy, and sudden death.",
keywords = "Anabolic steroids, Atrial fibrillation, Dysrhythmia",
author = "Sullivan, {Mack L.} and Martinez, {Charles M.} and Gallagher, {E. John}",
year = "1999",
month = "9",
doi = "10.1016/S0736-4679(99)00095-5",
language = "English (US)",
volume = "17",
pages = "851--857",
journal = "Journal of Emergency Medicine",
issn = "0736-4679",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Atrial fibrillation and anabolic steroids

AU - Sullivan, Mack L.

AU - Martinez, Charles M.

AU - Gallagher, E. John

PY - 1999/9

Y1 - 1999/9

N2 - A young male bodybuilder, consuming large doses of anabolic steroids (AS), presented to the Emergency Department (ED) with symptomatic rapid atrial fibrillation (AF). Echocardiogram revealed significant septal hypokinesis, and posterior and septal wall thickness at the upper limit of normal for highly trained athletes. The atrial fibrillation had not recurred at 10 weeks after discontinuation of AS use. Consumption of these agents in athletes has been associated with hypertension, ischemic heart disease, hypertrophic cardiomyopathy, and sudden death.

AB - A young male bodybuilder, consuming large doses of anabolic steroids (AS), presented to the Emergency Department (ED) with symptomatic rapid atrial fibrillation (AF). Echocardiogram revealed significant septal hypokinesis, and posterior and septal wall thickness at the upper limit of normal for highly trained athletes. The atrial fibrillation had not recurred at 10 weeks after discontinuation of AS use. Consumption of these agents in athletes has been associated with hypertension, ischemic heart disease, hypertrophic cardiomyopathy, and sudden death.

KW - Anabolic steroids

KW - Atrial fibrillation

KW - Dysrhythmia

UR - http://www.scopus.com/inward/record.url?scp=0033199425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033199425&partnerID=8YFLogxK

U2 - 10.1016/S0736-4679(99)00095-5

DO - 10.1016/S0736-4679(99)00095-5

M3 - Article

VL - 17

SP - 851

EP - 857

JO - Journal of Emergency Medicine

JF - Journal of Emergency Medicine

SN - 0736-4679

IS - 5

ER -